Fecal microbiota transplantation in inflammatory bowel disease: The quest for the holy grail

Mucosal Immunology

Volumn 9, Issue 6, 2016, Pages 1360-1365

  Pigneur, B ^a,b,c   Sokol, H ^c,d,e  

^a IMAGINE INSTITUTE   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c French Group of Faecal Microbiota Transplantation (GFTF)   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e AGROPARISTECH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EFFECTIVENESS; COMORBIDITY; CROHN DISEASE; DONOR SELECTION; FECAL MICROBIOTA TRANSPLANTATION; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MICROBIAL COLONIZATION; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TIME TO TREATMENT; TREATMENT INDICATION; ULCERATIVE COLITIS; ANIMAL; COLITIS, ULCERATIVE; DONOR; FECES; INFLAMMATORY BOWEL DISEASES; MICROBIOLOGY; MICROFLORA; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME;

ANIMALS; COLITIS, ULCERATIVE; CROHN DISEASE; FECAL MICROBIOTA TRANSPLANTATION; FECES; HUMANS; INFLAMMATORY BOWEL DISEASES; MICROBIOTA; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84991688488     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.67     Document Type: Review

References (50)

1. Khor, B., Gardet, A., & Xavier, R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307-317 (2011
2. Sokol, H., & Seksik, P. The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Curr. Opin. Gastroenterol. 26, 327-331 (2010
3. Sokol, H., et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15, 1183-1189 (2009
4. Manichanh, C., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211 (2006
5. Mangin, I., et al. Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol. Ecol. 50, 25-36 (2004
6. Gevers, D., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382-392 (2014
7. Morgan, X.C., et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012
8. Van Nood, E., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407-415 (2013
9. Leffler, D.A., & Lamont, J.T. Clostridium difficile infection. N. Engl. J. Med. 373, 287-288 (2015
10. Gupta, S., Allen-Vercoe, E., & Petrof, E.O. Fecal microbiota transplantation: in perspective. Therap. Adv. Gastroenterol. 9, 229-239 (2016
11. Angelberger, S., et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am. J. Gastroenterol. 108, 1620-1630 (2013
12. Suskind, D.L., Singh, N., Nielson, H., & Wahbeh, G. Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 60, 27-29 (2015
13. Cui, B., et al. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J. Transl. Med. 13, 298 (2015
14. Kunde, S., et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 56, 597-601 (2013
15. Colman, R.J., & Rubin, D.T. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-Analysis. J. Crohns Colitis 8, 1569-1581 (2014
16. Landy, J., et al. Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis. Sci. Rep. 5, 12955 (2015
17. Fang, S., et al. Successful treatment of chronic Pouchitis utilizing fecal microbiota transplantation (FMT): a case report. Int. J. Colorectal Dis. 31, 1093-1094 (2016
18. Moayyedi, P., et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149, 102-109.e106 (2015
19. Rossen, N.G., et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149, 110-118 e114 (2015
20. Sha, S., et al. Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment. Pharmacol. Ther. 39, 1003-1032 (2014
21. Suskind, D.L., et al. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease. Inflamm. Bowel Dis. 21, 556-563 (2015
22. Cui, B., et al. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J. Gastroenterol. Hepatol. 30, 51-58 (2015
23. Kelly, C.R., et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 149, 223-237 (2015
24. De Leon, L.M.,Watson, J.B., & Kelly, C.R. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin. Gastroenterol. Hepatol. 11, 1036-1038 (2013
25. Khoruts, A., et al. Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin. Gastroenterol. Hepatol. (2016) (in press
26. Vermeire, S., et al. Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J. Crohns Colitis 10, 387-394 (2016
27. Baxter, M., Ahmad, T., Colville, A., & Sheridan, R. Fatal aspiration pneumonia as a complication of fecal microbiota transplant. Clin. Infect. Dis. 61, 136-137 (2015
28. Alang, N., & Kelly, C.R. Weight gain after fecal microbiota transplantation. Open Forum Infect. Dis. 2, ofv004 (2015
29. Grinspan, A.M., & Kelly, C.R. Fecal microbiota transplantation for ulcerative colitis: not just yet. Gastroenterology 149, 15-18 (2015
30. Sokol, H. Toward rational donor selection in faecal microbiota transplantation for IBD. J. Crohns Colitis 10, 375-376 (2016
31. Sokol, H., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 105, 16731-16736 (2008
32. Morrison, D.J., & Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7, 189-200 (2016
33. Ding, T., & Schloss, P.D. Dynamics and associations of microbial community types across the human body. Nature 509, 357-360 (2014
34. Subramanian, S., et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 510, 417-421 (2014
35. Li, S.S., et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352, 586-589 (2016
36. Kazerouni, A., Burgess, J., Burns, L.J., &Wein, L.M. Optimal screening and donor management in a public stool bank. Microbiome 3, 75 (2015
37. Gough, E., Shaikh, H., & Manges, A.R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53, 994-1002 (2011
38. Hamilton, M.J., Weingarden, A.R., Sadowsky, M.J., & Khoruts, A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridiumdifficile infection.Am. J.Gastroenterol. 107, 761-767 (2012
39. Cardona, S., et al. Storage conditions of intestinal microbiota matter in metagenomic analysis. BMC Microbiol. 12, 158 (2012
40. Lee, C.H., et al. Frozen vs fresh fecalmicrobiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 315, 142-149 (2016
41. Youngster, I., et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 312, 1772-1778 (2014
42. Kassam, Z., Lee, C.H., Yuan, Y., & Hunt, R.H. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and metaanalysis. Am. J. Gastroenterol. 108, 500-508 (2013
43. David, L.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563 (2014
44. Rawls, J.F., Mahowald, M.A., Ley, R.E., & Gordon, J.I. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 127, 423-433 (2006
45. Winter, S.E., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339, 708-711 (2013
46. Garrett, W.S., et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131, 33-45 (2007
47. Elinav, E., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011
48. Vrieze, A., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913-916.e917 (2012
49. Quevrain, E., et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 65, 415-425 (2016
50. Miquel, S., et al. Identification of metabolic signatures linked to antiinflammatory effects of Faecalibacterium prausnitzii. MBio 6 2015